Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 556,393 shares at $33.49 ($18.7M) on 2025-03-17, disclosed to the SEC on 2025-03-18.
Scheduled sale ($18.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.14 | 97,551 | $3.2M | 17.3% |
| 2 | $32.91 | 14,320 | $471K | 2.5% |
| 3 | $32.91 | 14,320 | $471K | 2.5% |
| 4 | $32.96 | 16,667 | $549K | 2.9% |
| 5 | $32.96 | 16,667 | $549K | 2.9% |
| 6 | $32.97 | 17,001 |
| $561K |
| 3.0% |
| 7 | $32.97 | 17,001 | $561K | 3.0% |
| 8 | $33.01 | 2,792 | $92K | 0.5% |
| 9 | $33.01 | 2,792 | $92K | 0.5% |
| 10 | $33.49 | 27,347 | $916K | 4.9% |
| 11 | $33.49 | 27,347 | $916K | 4.9% |
| 12 | $33.55 | 40,447 | $1.4M | 7.3% |
| 13 | $33.55 | 40,447 | $1.4M | 7.3% |
| 14 | $34.15 | 7,087 | $242K | 1.3% |
| 15 | $34.15 | 7,087 | $242K | 1.3% |
| 16 | $35.28 | 50,000 | $1.8M | 9.4% |
| 17 | $33.75 | 57,713 | $1.9M | 10.4% |
| 18 | $33.75 | 57,713 | $1.9M | 10.4% |
| 19 | $34.13 | 21,047 | $718K | 3.8% |
| 20 | $34.13 | 21,047 | $718K | 3.8% |
| Total | $33.62 avg | 556,393 | $18.7M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |